Association of Borderline Personality Disorder and Antisocial Personality Disorders with Substance Use Disorder in a Teaching Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i7.2959Keywords:
Substance Use Disorder, Borderline personality disorder, Antisocial personality disorder, Comorbidity, PakistanRemove Substance use disorder, PakistanAbstract
Background: Substance use disorder is frequently associated with psychiatric comorbidity, particularly personality disorders, which can complicate treatment and worsen outcomes. Data on the prevalence and patterns of personality disorders among individuals with substance use disorder in Pakistan remain limited. Objective: To determine the frequency of Borderline Personality Disorder and Antisocial Personality Disorder and examine their association with sociodemographic factors among patients with substance use disorder. Methods: This cross-sectional study was conducted at a tertiary-care teaching hospital in Pakistan from 31 Dec 2024 to 31 May 2025. Male patients aged 18–60 years diagnosed with substance use disorder were recruited using consecutive sampling. Borderline Personality Disorder was assessed using the English version of the McLean Screening Instrument for Borderline Personality Disorder, while Antisocial Personality Disorder was diagnosed using the Urdu version of the Mini International Neuropsychiatric Interview (MINI 7.0.2). Sociodemographic and clinical data were collected using a structured proforma. Data were analyzed using descriptive statistics and chi-square tests. Results: A total of 88 participants were included. Borderline Personality Disorder was identified in 42.0% of participants, while Antisocial Personality Disorder was present in 58.0%. A significant comorbidity was observed between Borderline Personality Disorder and Antisocial Personality Disorder, with a higher proportion of individuals with Borderline Personality Disorder also meeting criteria for Antisocial Personality Disorder. Antisocial Personality Disorder was significantly more common among participants residing in rural areas, whereas no significant association was found between residence and Borderline Personality Disorder. Conclusion: Personality disorders, particularly Borderline Personality Disorder and Antisocial Personality Disorder, are highly prevalent among patients with substance use disorder, with substantial comorbidity between the two conditions. These findings highlight the importance of routine screening for personality disorders in substance use treatment settings and support the integration of comprehensive psychiatric assessment into addiction care.
Downloads
References
1. World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. Geneva: World Health Organization; 2024.
https://www.who.int/publications/i/item/9789240096745
2. World Health Organization. Mental health atlas 2024. Geneva: World Health Organization; 2024.
https://www.who.int/publications/i/item/9789240114487
3. World Health Organization. World mental health report: transforming mental health for all. Geneva: World Health Organization; 2022.
https://www.who.int/publications/i/item/9789240049338
4. United Nations Office on Drugs and Crime. World drug report 2024. Vienna: United Nations Office on Drugs and Crime; 2024.
:https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html
5. Aas CF, Vold JH, Gjestad R, Skurtveit S, Lim AG, Gjerde KV, et al. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst Abuse Treat Prev Policy. 2021; 16:20.
https://doi.org/10.1186/s13011-021-00354-1
6. Carpenter RW. The co-occurrence of personality disorders and substance use disorders: recent advances and clinical implications. Curr Psychiatry Rep. 2023; 25:1-10.
https://doi.org/10.1007/s11920-023-01452-6
7. Pandey S, Bolstad I, Lien L, Bramness JG. Antisocial personality disorder among patients in treatment for alcohol use disorder: characteristics and predictors of early relapse or drop-out. Subst Abuse Rehabil. 2021; 12:11-22.
https://doi.org/10.2147/SAR.S296526
8. Wong RSY. Psychopathology of antisocial personality disorder: from the structural, functional and biochemical perspectives. Egypt J Neurol Psychiatr Neurosurg. 2023; 59:113.
https://doi.org/10.1186/s41983-023-00717-4
9. Saddiqua A, Zunnurain MZ. Prevalence of anti-social behavior among women with substance use disorder in Pakistan. Adiktologie. 2024;24(2):81-87.
https://doi.org/10.35198/01-2024-002-0004
10. For borderline personality disorder: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003;17(6):568-73.
11. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33.
https://doi.org/10.1016/s0924-9338(97)83296-8
12. Munawar K, Aqeel M, Rehna T, Shuja KH, Bakrin FS, Choudhry FR. Validity and reliability of the Urdu version of the McLean Screening Instrument for Borderline Personality Disorder. Front Psychol. 2021; 12:533526.
https://doi.org/10.3389/fpsyg.2021.533526.
13. Sheehan DV, Lecrubier Y, Harnett Sheehan K, Janavs J, Weiller E, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12(5):232-41.
https://doi.org/10.1016/s0924-9338(97)83297-x
14. Mapi Research Trust. Mini International Neuropsychiatric Interview (MINI): official instrument information and translations. Lyon: Mapi Research Trust; 2025.
https://eprovide.mapi-trust.org/instruments/mini-international-neuropsychiatric-interview
15. Aas CF, Vold JH, Gjestad R, Skurtveit S, Bramness JG. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Substance Abuse Treatment, Prevention, and Policy. 2021; 16:20.
https://doi.org/10.1186/s13011-021-00354-1
16. Carpenter RW. The co-occurrence of personality disorders and substance use disorders: recent advances and clinical implications. Current Psychiatry Reports. 2023; 25:1–10.
https://doi.org/10.1007/s11920-023-01452-6
17. Wong RSY. Structural and biochemical correlates of antisocial personality disorder. Neuroscience and Biobehavioral Reviews. 2023;144:104971.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.